This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: All India exam, Subject name: Pharmacology
Lutetium dotatate was approved by FDA in 2018 for 
Select and explain. 
A. TB, B. Neuroendocrine tumours, C. Crohn's disease, D. Peptic ulcer
B: Neuroendocrine tumours
Answer: B: Neuroendocrine tumours 
Explanation: Lutetium (Lu 177) dotatate a radiolabeled somatostatin analogue, for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumours in adults.